Tranexamic acid for hyperfibrinolytic hemorrhage during conservative management of placenta percreta

Obstetrics and Gynecology

Volumn 126, Issue 5, 2015, Pages 1012-1015

  Schröder, Lars ^a   Pötzsch, Bernd ^a   Rühl, Heiko ^a   Gembruch, Ulrich ^a   Merz, Waltraut M ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; D DIMER; ENOXAPARIN; FIBRINOGEN; MISOPROSTOL; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; CASE REPORT; CHRONOTHERAPY; CONSERVATIVE TREATMENT; CURETTAGE; DRUG EFFICACY; EMBOLISM PREVENTION; FEMALE; GINGIVA BLEEDING; HEMOSTASIS; HEPARINIZATION; HUMAN; HYPOFIBRINOGENEMIA; ISOLATED HYPERFIBRINOLYSIS; PARTIAL THROMBOPLASTIN TIME; PLACENTA ACCRETA; PRIORITY JOURNAL; PROTHROMBIN TIME; SKIN BRUISING; THROMBOEMBOLISM; THROMBOSIS PREVENTION; TIME TO TREATMENT; TREATMENT DURATION; VAGINA BLEEDING; FIBRINOLYSIS; HEMORRHAGE; PREGNANCY;

ADULT; ANTIFIBRINOLYTIC AGENTS; FEMALE; FIBRINOLYSIS; HEMORRHAGE; HUMANS; PLACENTA ACCRETA; PREGNANCY; TRANEXAMIC ACID;

EID: 84945124101     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000915     Document Type: Article

References (8)

1. Silver RM, Fox KA, Barton JR, Abuhamad AZ, Simhan H, Huls CK, et al. Center of excellence for placenta accreta. Am J Obstet Gynecol 2014 [Epub ahead of print].
2. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol 2005;192:1458-61.
3. Sentilhes L, Amroselli C, Kayem G, Provansal M, Fernandez H, Perrotin F, et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol 2010;115:526-34.
4. Merz W, van de Vondel P, Strunk H, Geipel A, Gembruch U. Diagnosis, treatment and application of color Doppler in conservative management of abnormally adherent placenta. Ultraschall Med 2009;30:571-6.
5. Clausen C, Lönn L, Langhoff-Roos J. Management of placenta percreta: a review of published cases. Acta Obstet Gynecol Scand 2014;93:138-43.
6. Pather S, Strockyj S, Richards A, Campbell N, de Vries B, Ogle R. Maternal outcome after conservative management of placenta percreta at caesarean section: a report of three cases and a review of the literature. Aust N Z J Obstet Gynaecol 2014;54:84-7.
7. Sun M, Liu Y, Gibb W. Distribution of annexin I and II in term human fetal membranes, decidua and placenta. Placenta 1996; 17:181-4.
8. McCormack PL. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. Drugs 2012;72:585-617.